Healthy Returns: Eli Lilly, Novo Nordisk are competing to develop more convenient weekly insulins

The rivalry between Eli Lilly and Novo Nordisk extends beyond weight loss and diabetes drugs. Meanwhile, Uber has announced new features for caregivers.